Exciting, Challenging, and Insightful – This Is the Impression Pyry Simi, an 18-year-old from Tampere, Gained of the Pharmaceutical Industry After Spending a Day with Outi Vaarala, SVP of Innovative Medicines & R&D at Orion. Through the Job Shadow Day…
ScaleReady, in partnership with Wilson Wolf Manufacturing and Bio-Techne Corporation (NASDAQ: TECH), has announced that Luminary Therapeutics has been awarded a $300,000 G-Rex® Grant. This funding will facilitate rapid process development and IND-enabling studies for several novel CAR γδ T…
The World Health Organization (WHO) has released its latest report on tuberculosis (TB), revealing that 8.2 million people were newly diagnosed in 2023—the highest number since WHO began tracking TB globally in 1995. This increase, up from 7.5 million in…
Merck (NYSE: MRK), known as MSD in markets outside the United States and Canada, and Moderna, Inc. (Nasdaq: MRNA), have announced the launch of INTerpath-009, a pivotal Phase 3 randomized clinical trial assessing V940 (mRNA-4157), an investigational individualized neoantigen therapy,…
Walgreens is expanding its virtual healthcare service to enhance access for patients nationwide. As of October 1, Walgreens Virtual Healthcare is now available in 30 states, a significant increase from its initial launch in nine states. This expansion is designed…
Merck (NYSE: MRK), also known as MSD outside the U.S. and Canada, and Moderna, Inc. (Nasdaq: MRNA), announced the launch of INTerpath-009, a Phase 3 randomized clinical trial investigating V940 (mRNA-4157), an individualized neoantigen therapy (INT), combined with KEYTRUDA® (pembrolizumab),…
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has launched WuXia™ RidGS, an advanced glutamine synthetase (GS)-knockout Chinese hamster ovary (CHO) expression system platform. Designed for antibiotic-free cell line development, this platform utilizes zinc finger…
Judo Bio, a biotechnology company focused on developing oligonucleotide medicines for kidney delivery, has announced the presentation of preclinical data demonstrating a mechanism for the uptake and trafficking of ligand-siRNA conjugates via megalin receptors. This mechanism enables targeted gene knockdown…
Novartis presented promising 12-month results from its Phase III APPEAR-C3G study at the 2024 American Society of Nephrology (ASN) Kidney Week. These findings show that patients with C3 glomerulopathy (C3G) who received oral Fabhalta® (iptacopan) alongside supportive care maintained clinically…
Felix Health, a virtual care provider dedicated to helping Canadians manage their everyday health needs, is excited to be the presenting sponsor of the National Menopause Show. Set to attract around 3,000 attendees, this groundbreaking event in Canada focuses on…
LabGenomics USA has successfully acquired Integrated Molecular Diagnostics (IMD) CLIA labs, increasing its total number of CLIA-certified labs in the U.S. to four. This acquisition enhances LabGenomics’ strategic growth and expands its diagnostic services nationwide, particularly in molecular technology. In…
Eli Lilly and Company has reported encouraging findings regarding its treatment EBGLYSS, showing significant improvements in skin condition and itch relief for patients suffering from moderate-to-severe atopic dermatitis (eczema) who had previously been treated with dupilumab. These results, stemming from…